ZWINGENBERG & GREIFSWALD, Germany--(BUSINESS WIRE)--BRAIN AG, one of the leading European white biotechnology companies, has acquired a minority share in Enzymicals AG. This biotechnology company was founded in 2009 as a spin-off by a management team from the workgroup led by Prof. Dr. Uwe Bornscheuer from Ernst-Moritz-Arndt University Greifswald with support from the EXIST-Programme of the Federal Ministry for Economy and Technology (BMWi). The strategic investment of BRAIN AG in the Greifswald-based company that specializes in biocatalytic production of fine and special chemicals as well as enzyme production enhances the previous activities of both companies in the biocatalysis sector.
